EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Methylene Blue Administration Reduces Acute Kidney Injury After Living Donor Liver Transplantation: A Single‐Center Retrospective Study

Akira Katayama iD, Ezeldeen Abuelkasem iD, Yaroslava Longhitano iD, Raymond M Planinsic iD, Austin C Smith iD, David W Wang iD

Health Science Reports · 2026-03 · 9 (3)

DOI: 10.1002/hsr2.72025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 08.03.2026. Verfasst von Akira Katayama und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine University of Pittsburgh Pittsburgh PA USA. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims The efficacy of methylene blue (MB) in preventing acute kidney injury (AKI) in liver transplant recipients remains unclear. In this study, we hypothesized that pre‐reperfusion administration of MB decreases the incidence of postoperative AKI in living donor liver transplantation (LDLT).

Methods

We retrospectively analyzed data from 415 patients who underwent LDLT between January 2018 to June 2023. The MB group received a bolus of 1–1.5 mg/kg of MB just prior to graft reperfusion, and the control group did not receive MB. The primary outcome was the incidence of postoperative AKI for each stage, as defined by the Kidney Disease Improving Global Outcomes guidelines. Secondary outcomes included post‐reperfusion hemodynamics, hospital length of stay (LOS), the incidence of early allograft dysfunction (EAD), and mortality at 30‐days, 6‐months, and 1‐year.

Results

The incidence of postoperative AKI all stage and AKI stage 1 was significantly lower in the MB group compared to the control group (AKI all stage: 40.8% vs. 30.0%, p = 0.049, AKI stage 1: 34.7% vs. 23.3%, p = 0.03). In multivariable analysis, MB administration was independently associated with the incidence of AKI stage 1 (OR 0.59, 95% CI 0.36‐0.99, p = 0.046). Hemodynamics during post‐reperfusion period were similar among the groups. The incidence of EAD is significantly lower in MB group compared to control group, but hospital LOS and mortality at 30‐days, 6‐months, and 1‐year were similar in both groups.

Conclusion

The administration of MB just prior to graft reperfusion was associated with decreased incidence of postoperative AKI stage 1 in LDLT. MB administration was also associated with reduced incidence of EAD.

Schlagwörter

Stichwörter der Autor:innen

acute kidney injuryliver transplantationmethylene bluereperfusion injury

Autor:innen und Institutionen

  • Department of Anesthesiology and Perioperative Medicine University of Pittsburgh Pittsburgh PA USA.
  • Department of Anesthesiology and Resuscitology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan.

ORCID-Profile: Akira Katayama, Ezeldeen Abuelkasem, Yaroslava Longhitano, Raymond M Planinsic, Austin C Smith, David W Wang

Zitieren

APA

Katayama, A., Abuelkasem, E., Longhitano, Y., Planinsic, R. M., Smith, A. C., & Wang, D. W. (2026). Methylene Blue Administration Reduces Acute Kidney Injury After Living Donor Liver Transplantation: A Single‐Center Retrospective Study. Health Science Reports, 9(3). https://doi.org/10.1002/hsr2.72025

Vancouver

Katayama A, Abuelkasem E, Longhitano Y, Planinsic RM, Smith AC, Wang DW. Methylene Blue Administration Reduces Acute Kidney Injury After Living Donor Liver Transplantation: A Single‐Center Retrospective Study. Health Science Reports. 2026;9(3). doi:10.1002/hsr2.72025

BibTeX
@article{Katayama2026,
  author = {Katayama, Akira and Abuelkasem, Ezeldeen and Longhitano, Yaroslava and Planinsic, Raymond M and Smith, Austin C and Wang, David W},
  title = {Methylene Blue Administration Reduces Acute Kidney Injury After Living Donor Liver Transplantation: A Single‐Center Retrospective Study},
  journal = {Health Science Reports},
  year = {2026},
  volume = {9},
  number = {3},
  doi = {10.1002/hsr2.72025}
}
Kostenlos starten →